Frovatriptan Succinate 2.5 mg/1 (Frovatriptan Succinate TABLET, FILM COATED) 2.5 mg/1

Frovatriptan Succinate 2.5 mg is a medication used for managing migraine headaches. This oral tablet is designed to provide relief and is manufactured by Endo USA, Inc.

Strength

2.5 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (0603-3718-34) / 9 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

Endo USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Frovatriptan Succinate is commonly used for the treatment of migraine headaches. It works by narrowing blood vessels around the brain and reducing substances in the body that can trigger headache pain, nausea, sensitivity to light and sound, and other migraine symptoms. People often wonder, 'What is Frovatriptan Succinate used for?' It is specifically indicated for migraine attacks and not for other types of headaches or preventive treatment.

Side Effects

Common effects of Frovatriptan Succinate may include dizziness, drowsiness, and fatigue. Some users might experience nausea or dry mouth. These effects can vary from person to person and are generally mild to moderate in nature.

Precautions & Warnings

Frovatriptan Succinate should be handled with care. It is important to follow the prescribed dosage and administration instructions. Individuals with certain medical conditions, such as heart disease or high blood pressure, should consult a healthcare provider before use. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Frovatriptan Succinate may interact with other medications, including certain antidepressants, ergotamine, and other migraine treatments. It is advisable to inform a healthcare provider about all current medications before starting Frovatriptan Succinate. Alcohol consumption should be avoided as it may exacerbate side effects.

Frequently Asked Questions

Frovatriptan Succinate is used for the treatment of migraine headaches. It helps to relieve pain, nausea, and other symptoms associated with migraines.

Frovatriptan Succinate is taken orally, typically at the first sign of a migraine. Follow the dosage instructions provided by a healthcare professional.

Common side effects may include dizziness, drowsiness, fatigue, nausea, and dry mouth. These effects are usually mild and temporary.

No, Frovatriptan Succinate is not intended for preventive treatment. It is specifically designed for the acute treatment of migraine attacks.

Frovatriptan Succinate may not be suitable for everyone, especially those with certain medical conditions. Consult a healthcare provider for personalized advice.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.